DHODH and chronic myelogenous leukemia, BCR-ABL1 positive: The presence of cleaved PARP1 and cleaved Caspase 3 demonstrated the activation of the apoptotic pathways in CML cells treated with the DHODH inhibitor (Fig. 1D).